Patents by Inventor Jun Toyohara

Jun Toyohara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Drugs for the diagnosis of tissue reproductive activity or the treatment of proliferative diseases
    Patent number: 7118731
    Abstract: An agent which comprises, as an active ingredient, a radiolabeled compound as represented by the following formula or a pharmaceutically acceptable salt thereof: wherein R1 denotes hydrogen, or a linear- or branched-chain alkyl group having 1–8 carbon atoms, R2 denotes hydrogen, hydroxyl or a halogen substituent, R3 denotes hydrogen or fluorine substituent, R4 denotes oxygen, sulfur, or a methylene substituent, and R5 denotes a radioactive halogen substituent. The agent is stable in vivo, and either stays in cells or is incorporated in DNA, thus serving for diagnosis of tissue proliferation activity or treatment of proliferative disease.
    Type: Grant
    Filed: November 16, 2004
    Date of Patent: October 10, 2006
    Assignee: Nihon Medi-Physics Co., Ltd.
    Inventors: Jun Toyohara, Akio Hayashi
  • Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases
    Patent number: 7045115
    Abstract: An agent which comprises, as an active ingredient, a radiolabeled compound as represented by the following formula or a pharmaceutically acceptable salt thereof: wherein R1 denotes hydrogen, or a linear- or branched-chain alkyl group having 1–8 carbon atoms, R2 denotes hydrogen, hydroxyl or a halogen substituent, R3 denotes hydrogen or fluorine substituent, R4 denotes oxygen, sulfur, or a methylene substituent, and R5 denotes a radioactive halogen substituent. The agent is stable in vivo, and either stays in cells or is incorporated in DNA, thus serving for diagnosis of tissue proliferation activity or treatment of proliferative disease.
    Type: Grant
    Filed: January 22, 2002
    Date of Patent: May 16, 2006
    Assignee: Nihon Medi-Physics Co., Ltd.
    Inventors: Jun Toyohara, Akio Hayashi
  • Drugs for the diagnosis of tissue reproductive activity or the treatment of proliferative diseases
    Publication number: 20050129611
    Abstract: An agent which comprises, as an active ingredient, a radiolabeled compound as represented by the following formula or a pharmaceutically acceptable salt thereof: wherein R1 denotes hydrogen, or a linear- or branched-chain alkyl group having 1-8 carbon atoms, R2 denotes hydrogen, hydroxyl or a halogen substituent, R3 denotes hydrogen or fluorine substituent, R4 denotes oxygen, sulfur, or a methylene substituent, and R denotes a radioactive halogen substituent. The agent is stable in vivo, and either stays in cells or is incorporated in DNA, thus serving for diagnosis of tissue proliferation activity or treatment of proliferative disease.
    Type: Application
    Filed: November 16, 2004
    Publication date: June 16, 2005
    Applicant: Nihon Medi-Physics Co., Ltd.
    Inventors: Jun Toyohara, Akio Hayashi
  • Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases
    Publication number: 20030124054
    Abstract: An agent which comprises, as an active ingredient, a radiolabeled compound as represented by the following formula or a pharmaceutically acceptable salt thereof: 1
    Type: Application
    Filed: September 23, 2002
    Publication date: July 3, 2003
    Inventors: Jun Toyohara, Akio Hayashi